Yoshio Yamaoka Selected Research

Duodenal Ulcer (Curling's Ulcer)

11/2021	Genome-wide association study of gastric cancer- and duodenal ulcer-derived Helicobacter pylori strains reveals discriminatory genetic variations and novel oncoprotein candidates.
4/2015	Influence of prostate stem cell antigen gene polymorphisms on susceptibility to Helicobacter pylori-associated diseases: a case-control study.
10/2010	Systematic review and meta-analysis: the relationship between the Helicobacter pylori dupA gene and clinical outcomes.
10/2009	homB status of Helicobacter pylori as a novel marker to distinguish gastric cancer from duodenal ulcer.
4/2009	Proteomic Helicobacter pylori biomarkers discriminating between duodenal ulcer and gastric cancer.
7/2008	vacA genotypes of Helicobacter pylori in relation to cagA status and clinical outcomes in Iranian populations.
10/2007	Helicobacter pylori environmental interactions: effect of acidic conditions on H. pylori-induced gastric mucosal interleukin-8 production.
11/2005	Helicobacter pylori virulence factors: facts and fantasies.
12/2004	The interleukin-1 RN polymorphism and Helicobacter pylori infection in the development of duodenal ulcer.
6/2002	Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshio Yamaoka Research Topics

Disease

89	Infections 01/2022 - 01/2002
46	Stomach Neoplasms (Stomach Cancer) 11/2021 - 09/2002
33	Neoplasms (Cancer) 09/2020 - 01/2002
23	Inflammation (Inflammations) 01/2022 - 08/2002
12	Gastritis 01/2022 - 06/2002
12	Hepatocellular Carcinoma (Hepatoma) 09/2006 - 03/2002
11	Duodenal Ulcer (Curling's Ulcer) 11/2021 - 01/2002
10	Atrophy 08/2021 - 08/2002
9	Fibrosis (Cirrhosis) 01/2010 - 04/2002
8	Peptic Ulcer (Peptic Ulcers) 01/2018 - 01/2002
7	Metaplasia 01/2018 - 08/2002
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2010 - 04/2002
6	Ischemia 12/2006 - 02/2002
6	Neoplasm Metastasis (Metastasis) 08/2004 - 01/2002
5	Atrophic Gastritis 04/2020 - 03/2010
5	Reperfusion Injury 01/2014 - 04/2003
4	Persistent Infection 03/2022 - 10/2014
4	Carcinoma (Carcinomatosis) 12/2016 - 01/2008
4	Carcinogenesis 03/2012 - 12/2002
4	Hepatitis 01/2005 - 05/2002
3	Stomach Diseases 03/2022 - 03/2016
3	Chronic Hepatitis (Chronic Active Hepatitis) 09/2006 - 02/2002
3	Ulcer 04/2005 - 01/2002
2	Hemorrhage 01/2022 - 01/2002
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2022 - 01/2016
2	Bacterial Infections (Bacterial Infection) 01/2017 - 01/2008
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2017 - 12/2002
2	Stomach Ulcer (Gastric Ulcer) 01/2015 - 11/2003
2	Communicable Diseases (Infectious Diseases) 08/2007 - 01/2005
2	Liver Diseases (Liver Disease) 09/2006 - 08/2004
2	Liver Neoplasms (Liver Cancer) 09/2006 - 01/2002
2	Liver Failure 08/2004 - 04/2002
2	Colonic Neoplasms (Colon Cancer) 02/2002 - 02/2002
2	Thrombosis (Thrombus) 01/2002 - 01/2002

Drug/Important Bio-Agent (IBA)

26	Virulence Factors (Pathogenicity Factors)IBA 01/2022 - 06/2002
17	Proteins (Proteins, Gene)FDA Link 03/2022 - 02/2002
17	Interleukin-8 (Interleukin 8)IBA 01/2020 - 08/2002
14	Messenger RNA (mRNA)IBA 10/2017 - 12/2002
9	Biomarkers (Surrogate Marker)IBA 11/2021 - 04/2002
8	UreaseIBA 01/2022 - 05/2013
8	CytokinesIBA 02/2019 - 04/2005
8	AntralIBA 01/2019 - 04/2005
7	Cytotoxins (Cytolysins)IBA 01/2021 - 11/2005
7	Anti-Bacterial Agents (Antibiotics)IBA 10/2020 - 01/2008
7	DNA (Deoxyribonucleic Acid)IBA 04/2018 - 02/2002
7	AntibodiesIBA 01/2017 - 06/2004
6	AntigensIBA 01/2022 - 02/2002
6	Interleukin-6 (Interleukin 6)IBA 01/2015 - 12/2002
6	alpha-Fetoproteins (alpha-Fetoprotein)IBA 06/2007 - 05/2002
6	Thioacetamide (Thioacetamid)IBA 01/2005 - 02/2003
5	Pepsinogen A (Pepsinogen)IBA 07/2021 - 10/2013
5	AcidsIBA 09/2020 - 01/2009
5	InterleukinsIBA 11/2011 - 12/2002
4	Interleukin-17 (Interleukin 17)IBA 01/2021 - 12/2008
4	Pharmaceutical PreparationsIBA 10/2020 - 06/2003
4	Blood Group Antigens (Blood Groups)IBA 03/2011 - 12/2004
3	Metronidazole (Metric)FDA LinkGeneric 01/2022 - 01/2019
3	Oncogene Proteins (Oncogene Protein)IBA 11/2021 - 04/2012
3	Immunoglobulin G (IgG)IBA 07/2021 - 01/2017
3	Cytochrome P-450 CYP2C19IBA 04/2021 - 01/2015
3	Clarithromycin (Biaxin)FDA LinkGeneric 01/2019 - 05/2017
3	Levofloxacin (Levaquin)FDA Link 01/2019 - 03/2016
3	SaltsIBA 09/2018 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2009 - 08/2004
3	Interleukin-18 (Interleukin 18)IBA 11/2009 - 01/2008
3	Biological ProductsIBA 11/2005 - 02/2002
3	ThioredoxinsIBA 01/2005 - 05/2003
3	Ethanol (Ethyl Alcohol)IBA 12/2004 - 01/2002
3	Complementary DNA (cDNA)IBA 01/2004 - 12/2002
3	Indicators and Reagents (Reagents)IBA 02/2002 - 01/2002
2	Small Interfering RNA (siRNA)IBA 11/2021 - 12/2016
2	16S Ribosomal RNAIBA 06/2021 - 01/2020
2	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2021 - 06/2008
2	PepsinogensIBA 01/2020 - 01/2015
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019 - 12/2002
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 04/2018 - 01/2017
2	Proton Pump InhibitorsIBA 01/2018 - 01/2009
2	Cadherins (E-Cadherin)IBA 03/2016 - 05/2006
2	PhosphotyrosineIBA 01/2016 - 01/2014
2	Interleukin-10 (Interleukin 10)IBA 01/2015 - 01/2015
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2014 - 11/2003
2	Phosphotransferases (Kinase)IBA 06/2012 - 01/2009
2	Angiotensin IIIBA 03/2012 - 12/2004
2	Transcription Factors (Transcription Factor)IBA 01/2008 - 03/2007
2	InterferonsIBA 03/2007 - 04/2004
2	ElementsIBA 03/2007 - 04/2004
2	NF-kappa B (NF-kB)IBA 03/2007 - 03/2005
2	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 05/2006 - 02/2003
2	Interleukin-1 (Interleukin 1)IBA 12/2004 - 12/2002
2	ChemokinesIBA 08/2004 - 06/2004
2	OligonucleotidesIBA 01/2004 - 06/2003

Therapy/Procedure

20	Therapeutics 01/2021 - 01/2002
5	Palliative Care (Palliative Therapy) 12/2015 - 08/2008
4	Warm Ischemia 01/2014 - 02/2002
3	Hepatectomy 04/2005 - 05/2002
2	Renal Dialysis (Hemodialysis) 02/2011 - 01/2009
2	Transplantation 09/2005 - 08/2005
2	Liver Transplantation 09/2005 - 03/2002
2	Intraperitoneal Injections 01/2004 - 03/2003
2	Ligation 02/2003 - 01/2002